BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

608 related articles for article (PubMed ID: 28739288)

  • 1. Recent advances on extracellular vesicles in therapeutic delivery: Challenges, solutions, and opportunities.
    Lu M; Xing H; Yang Z; Sun Y; Yang T; Zhao X; Cai C; Wang D; Ding P
    Eur J Pharm Biopharm; 2017 Oct; 119():381-395. PubMed ID: 28739288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracellular vesicles for drug delivery.
    Vader P; Mol EA; Pasterkamp G; Schiffelers RM
    Adv Drug Deliv Rev; 2016 Nov; 106(Pt A):148-156. PubMed ID: 26928656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospects and challenges of extracellular vesicle-based drug delivery system: considering cell source.
    Meng W; He C; Hao Y; Wang L; Li L; Zhu G
    Drug Deliv; 2020 Dec; 27(1):585-598. PubMed ID: 32264719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Good things come in small packages: Overcoming challenges to harness extracellular vesicles for therapeutic delivery.
    Ingato D; Lee JU; Sim SJ; Kwon YJ
    J Control Release; 2016 Nov; 241():174-185. PubMed ID: 27667180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Challenges and Possibilities of Extracellular Vesicles as Therapeutic Vehicles.
    Melling GE; Carollo E; Conlon R; Simpson JC; Carter DRF
    Eur J Pharm Biopharm; 2019 Nov; 144():50-56. PubMed ID: 31419585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracellular Vesicles - Advanced Nanocarriers in Cancer Therapy: Progress and Achievements.
    Huyan T; Li H; Peng H; Chen J; Yang R; Zhang W; Li Q
    Int J Nanomedicine; 2020; 15():6485-6502. PubMed ID: 32922012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracellular Vesicles as an Efficient and Versatile System for Drug Delivery.
    Dang XTT; Kavishka JM; Zhang DX; Pirisinu M; Le MTN
    Cells; 2020 Sep; 9(10):. PubMed ID: 33003285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracellular Vesicles as Drug Delivery Vehicles to the Central Nervous System.
    Shahjin F; Chand S; Yelamanchili SV
    J Neuroimmune Pharmacol; 2020 Sep; 15(3):443-458. PubMed ID: 31485884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methods for loading therapeutics into extracellular vesicles and generating extracellular vesicles mimetic-nanovesicles.
    Nasiri Kenari A; Cheng L; Hill AF
    Methods; 2020 May; 177():103-113. PubMed ID: 31917274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancing the Therapeutic Potential of Extracellular Vesicles Using Peptide Technology.
    Martin Perez C; Conceição M; Raz R; Wood MJA; Roberts TC
    Methods Mol Biol; 2022; 2383():119-141. PubMed ID: 34766286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracellular Vesicle (EV) biohybrid systems for cancer therapy: Recent advances and future perspectives.
    Ou YH; Liang J; Czarny B; Wacker MG; Yu V; Wang JW; Pastorin G
    Semin Cancer Biol; 2021 Sep; 74():45-61. PubMed ID: 33609664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delivery of Biomolecules via Extracellular Vesicles: A Budding Therapeutic Strategy.
    Stranford DM; Leonard JN
    Adv Genet; 2017; 98():155-175. PubMed ID: 28942793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiplexed strategies toward clinical translation of extracellular vesicles.
    Song J; Song B; Yuan L; Yang G
    Theranostics; 2022; 12(15):6740-6761. PubMed ID: 36185609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracellular Vesicles in Cardiovascular Diseases: Alternative Biomarker Sources, Therapeutic Agents, and Drug Delivery Carriers.
    Chong SY; Lee CK; Huang C; Ou YH; Charles CJ; Richards AM; Neupane YR; Pavon MV; Zharkova O; Pastorin G; Wang JW
    Int J Mol Sci; 2019 Jul; 20(13):. PubMed ID: 31277271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracellular vesicles as natural therapeutic agents and innate drug delivery systems for cancer treatment: Recent advances, current obstacles, and challenges for clinical translation.
    Pirisinu M; Pham TC; Zhang DX; Hong TN; Nguyen LT; Le MT
    Semin Cancer Biol; 2022 May; 80():340-355. PubMed ID: 32977006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracellular Vesicles as Biological Shuttles for Targeted Therapies.
    Raimondo S; Giavaresi G; Lorico A; Alessandro R
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 30991632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracellular Vesicles in Modifying the Effects of Ionizing Radiation.
    Szatmári T; Hargitai R; Sáfrány G; Lumniczky K
    Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31698689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent Advancement and Technical Challenges in Developing Small Extracellular Vesicles for Cancer Drug Delivery.
    Geng T; Pan P; Leung E; Chen Q; Chamley L; Wu Z
    Pharm Res; 2021 Feb; 38(2):179-197. PubMed ID: 33604783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A call for the standardised reporting of factors affecting the exogenous loading of extracellular vesicles with therapeutic cargos.
    Rankin-Turner S; Vader P; O'Driscoll L; Giebel B; Heaney LM; Davies OG
    Adv Drug Deliv Rev; 2021 Jun; 173():479-491. PubMed ID: 33862168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracellular vesicles as an efficient nanoplatform for the delivery of therapeutics.
    Liu C; Gao H; Lv P; Liu J; Liu G
    Hum Vaccin Immunother; 2017 Nov; 13(11):2678-2687. PubMed ID: 28949786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.